Market by Drug Type, Technology, Service, End-user, and Country | Forecast 2019-2028
The Asia-Pacific drug discovery market is expected to reach a significant growth with a CAGR of 6.88% in terms of revenue over the forecasting years 2019-2028.
Report scope can be customized per your requirements. Request For Customization
The drug discovery
market in Asia-Pacific comprises the following countries:
• China
• India
• Japan
• South Korea
• Australia & New Zealand
• ASEAN countries
• Rest of APAC
Companies in Japan are
focusing on drug discovery processes, and have been witnessing numerous
advancements in terms of drug development. This is propelling the market in a
forward direction. A report from the Japanese government states that the
companies operating in the country have developed a revolutionary system, the
Peptide Discovery Platform System (PPDS). This system helps create millions of
peptides manually. It can also be used to extract these peptides for developing
a new drug. The primary reason for
creating such a system is that non-standard peptides can develop a drug having
fewer no side-effects. Thus, the importance of the PPDS system has increased in Japan, and the country is taking a step ahead for drug discovery purposes.
This is expected to benefit the Japanese drug discovery market significantly in
the coming years.
Pharmaceutical
companies based in China are steadily moving from manufacturing low-cost
generics to the process of new drug discovery itself. The nation has
established a large-scale chemical library for R&D purposes for new drugs.
This has led to the discovery of a series of lead compounds by integrating data
obtained from different technology-based strategies. India has been contributing to the
growth of the drug discovery market by initiating in-house drug discovery
projects across the country. The Indian government has been taking numerous initiatives,
such as the Pharma Vision 2020, to make India one of the leading destinations in
the world for end-to-end drug manufacturing.
Eli Lilly and Company is a drug manufacturing company that is
engaged in developing, manufacturing, and making its products in two segments, namely
human pharmaceutical products and animal health products. The company provides
its products in various areas of specialty medicine like cardiovascular
disease, diabetes, neuroscience, endocrine diseases, urology, and oncology. The
company has a notable presence in the Asia-Pacific. It has entered into
partnerships with many companies in India and China.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. ASIA-PACIFIC
DRUG DISCOVERY MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER'S
FIVE FORCES MODEL
2.2.1. THREATS
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTE PRODUCTS
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. COMPETITIVE
RIVALRY
2.3. COVID-19
AND ITS IMPACT ON DRUG DISCOVERY MARKET
2.4. PESTLE
OUTLOOK
2.5. REGULATORY
FRAMEWORK
2.6. VALUE
CHAIN OUTLOOK
2.7. MARKET
ATTRACTIVENESS INDEX
2.8. KEY
INSIGHT
2.9. MARKET
DRIVERS
2.9.1. GROWING
AGED POPULATION
2.9.2. TECHNOLOGICAL
ADVANCEMENTS
2.9.3. RISE
IN HEALTHCARE EXPENDITURE
2.9.4. SURGE
IN LIFESTYLE-ORIENTED DISEASES
2.10. MARKET RESTRAINTS
2.10.1. DELAY IN PRODUCT LAUNCHES
2.10.2. RESTRICTED GROWTH RATE DUE TO GENERIC DRUGS
2.11. MARKET OPPORTUNITIES
2.11.1. SIGNIFICANT INVESTMENT BY HEALTHCARE INDUSTRIES
IN IMPROVING BIG DATA ANALYTICAL CAPABILITIES
2.11.2. RISING DEMAND FOR SPECIALTY MEDICINES
2.12. MARKET CHALLENGES
2.12.1. POOR REIMBURSEMENTS POLICIES IN EMERGING
NATIONS
2.12.2. STRINGENT GOVERNMENT REGULATIONS
3. DRUG
DISCOVERY MARKET OUTLOOK - BY DRUG TYPE
3.1. SMALL
MOLECULE DRUG
3.2. BIOLOGIC
DRUG
4. DRUG
DISCOVERY MARKET OUTLOOK - BY TECHNOLOGY
4.1. HIGH
THROUGHPUT SCREENING
4.2. BIOCHIPS
4.3. BIOINFORMATICS
4.4. PHARMACOGENOMICS
AND PHARMACOGENETICS
4.5. COMBINATORIAL
CHEMISTRY
4.6. NANOTECHNOLOGY
4.7. SPECTROSCOPY
4.8. METABOLOMICS
4.9. OTHER
TECHNOLOGIES
5. DRUG
DISCOVERY MARKET OUTLOOK - BY SERVICE
5.1. DRUG
METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES
5.2. CHEMICAL
SERVICES
5.3. BIOLOGICAL
SERVICES
5.4. OTHER
PHARMACEUTICAL SERVICES
6. DRUG
DISCOVERY MARKET OUTLOOK - BY END-USER
6.1. RESEARCH
INSTITUTES
6.2. PHARMACEUTICAL
COMPANIES
6.3. CONTRACT
RESEARCH ORGANIZATIONS (CROS)
6.4. OTHER
END-USERS
7. DRUG
DISCOVERY MARKET – ASIA-PACIFIC
7.1. COUNTRY
ANALYSIS
7.1.1. CHINA
7.1.2. INDIA
7.1.3. JAPAN
7.1.4. SOUTH
KOREA
7.1.5. AUSTRALIA
& NEW ZEALAND
7.1.6. ASEAN
COUNTRIES
7.1.7. REST
OF ASIA-PACIFIC
8. COMPANY
PROFILES
8.1. 3M COMPANY
8.2. ABBOTT
LABORATORIES INC
8.3. AGILENT
TECHNOLOGIES INC
8.4. ANTARES
PHARMA INC
8.5. ASTRAZENECA
PLC
8.6. BAYER
AG
8.7. BECTON
DICKINSON & COMPANY (BD)
8.8. BOEHRINGER
INGELHEIM
8.9. ELI
LILY AND COMPANY
8.10. F HOFFMANN-LA ROCHE LTD
8.11. GLAXOSMITHKLINE LLC
8.12. JOHNSON & JOHNSON
8.13. MERCK & CO INC
8.14. NOVARTIS
8.15. PFIZER INC
8.16. SANOFI
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.1.1. OBJECTIVES
OF STUDY
9.1.2. SCOPE
OF STUDY
9.2. SOURCES
OF DATA
9.2.1. PRIMARY
DATA SOURCES
9.2.2. SECONDARY
DATA SOURCES
9.3. RESEARCH
METHODOLOGY
9.3.1. EVALUATION
OF PROPOSED MARKET
9.3.2. IDENTIFICATION
OF DATA SOURCES
9.3.3. ASSESSMENT
OF MARKET DETERMINANTS
9.3.4. DATA
COLLECTION
9.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY
COUNTRY, 2019-2028 ($ MILLION)
TABLE 2 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY
TECHNOLOGY, 2019-2028 ($ MILLION)
TABLE 3 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY
DRUG TYPE, 2019-2028 ($ MILLION)
TABLE 4 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY
SERVICE, 2019-2028 ($ MILLION)
TABLE 5 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY
END-USER, 2019-2028 ($ MILLION)
TABLE 6 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY
COUNTRY, 2019-2028 ($ MILLION)
FIGURE 1 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY
REGION, 2019-2028 ($ MILLION)
FIGURE 2 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY
SMALL MOLECULE DRUG, 2019-2028 ($ MILLION)
FIGURE 3 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY
BIOLOGIC DRUG, 2019-2028 ($ MILLION)
FIGURE 4 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY
HIGH THROUGHPUT SCREENING, 2019-2028 ($ MILLION)
FIGURE 5 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY
BIOCHIPS, 2019-2028 ($ MILLION)
FIGURE 6 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY
BIOINFORMATICS, 2019-2028 ($ MILLION)
FIGURE 7 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY
PHARMACOGENOMICS AND PHARMACOGENETICS, 2019-2028 ($ MILLION)
FIGURE 8 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY
COMBINATORIAL CHEMISTRY, 2019-2028 ($ MILLION)
FIGURE 9 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY
NANOTECHNOLOGY, 2019-2028 ($ MILLION)
FIGURE 10 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY
SPECTROSCOPY, 2019-2028 ($ MILLION)
FIGURE 11 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY
METABOLOMICS, 2019-2028 ($ MILLION)
FIGURE 12 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY OTHER
TECHNOLOGIES, 2019-2028 ($ MILLION)
FIGURE 13 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY DRUG
METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES, 2019-2028 ($ MILLION)
FIGURE 14 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY
CHEMICAL SERVICES, 2019-2028 ($ MILLION)
FIGURE 15 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY
BIOLOGICAL SERVICES, 2019-2028 ($ MILLION)
FIGURE 16 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY OTHER
PHARMACEUTICAL SERVICES, 2019-2028 ($ MILLION)
FIGURE 17 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY
RESEARCH INSTITUTES, 2019-2028 ($ MILLION)
FIGURE 18 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY
PHARMACEUTICAL COMPANIES, 2019-2028 ($ MILLION)
FIGURE 19 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY
CONTRACT RESEARCH ORGANIZATIONS (CROS), 2019-2028 ($ MILLION)
FIGURE 20 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY OTHER
END-USERS, 2019-2028 ($ MILLION)
FIGURE 21 CHINA DRUG DISCOVERY MARKET 2019-2028 ($
MILLION)
FIGURE 22 INDIA DRUG DISCOVERY MARKET 2019-2028 ($
MILLION)
FIGURE 23 JAPAN DRUG DISCOVERY MARKET 2019-2028 ($
MILLION)
FIGURE 24 SOUTH KOREA DRUG DISCOVERY MARKET 2019-2028
($ MILLION)
FIGURE 25 AUSTRALIA & NEW ZEALAND DRUG DISCOVERY
MARKET 2019-2028 ($ MILLION)
FIGURE 26 ASEAN COUNTRIES DRUG DISCOVERY MARKET
2019-2028 ($ MILLION)
FIGURE 27 REST OF ASIA-PACIFIC DRUG DISCOVERY MARKET
2019-2028 ($ MILLION)